Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Bruno, Stefania ^a   Collino, Federica ^b   Iavello, Alessandra ^b   Camussi, Giovanni ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti tumor effect; Extracellular vesicles; In vivo tumor models; Mesenchymal stem cells; Pro tumorigenic activity

Indexed keywords

5' NUCLEOTIDASE; ALPHA INTERFERON; BETA SECRETASE; BETA1 INTEGRIN; CASPASE 3; CHEMOKINE RECEPTOR CXCR4; CYCLINE; ENDOGLIN; HERMES ANTIGEN; MICRORNA; MICRORNA 122; MICRORNA 125B; MICRORNA 133B; MICRORNA 146A; MICRORNA 214; MICRORNA 223; MICRORNA 24; MICRORNA 31; MICRORNA 451; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN KINASE B; RAB PROTEIN; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CYTOFLUOROMETRY; DNA MICROARRAY; DNA MODIFICATION; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GLIOSARCOMA; HUMAN; IMMUNOREGULATION; KAPOSI SARCOMA; MEMBRANE VESICLE; MESENCHYMAL STROMA CELL; NECROSIS; NICK END LABELING; NONHUMAN; OVARY CANCER; SHORT SURVEY; TUMOR ENGRAFTMENT; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION;

EID: 84919480405     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00382     Document Type: Short Survey

References (64)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for denning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 8(4):315-7. doi:10.1080/14653240600855905
2. Prockop DJ. Marrow stromal cells as stem cells for not hematopoietic tissues. Science (1997) 276:71-4. doi:10.1126/science.276.5309.71
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284:143-7. doi:10.1126/science.284.5411.143
4. Collins JJ, Thebaud B. Lung mesenchymal stromal cells in development and disease: To serve and to protect? Antioxid Redox Signal (2014). Forthcoming.
5. Tobita M, Mizuno H. Adipose-derived stem cells and periodontal tissue engineering. Int. J. Oral Maxillofac Implants (2013) 28:e487-93. doi:10.11607/ jomi.te29
6. Hilkens P, Gervois P, Fanton Y, Vanormelingen I, Martens W, Struys T, et al. Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells. Cell Tissue Res (2013) 353:65-78. doi:10.1007/s00441-013-1630-x
7. Feisst V, Brooks A, Chen I, Dunbar PR. Characterization of mesenchymal progenitor cell populations directly derived from human dermis. Stem Cells Dev (2014) 23(6):631-42. doi:10.1089/scd.2013.0207
8. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell (2012) 10:709-16. doi:10.1016/j.stem.2012.05.015
9. Ii IF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells (2004) 22:415-27. doi:10.1634/stemcells.22-3-415
10. Togel F, Hu Z, Weiss K, Isaac I, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 289:F31-42. doi:10.1152/ajprenal.00007.2005
11. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int (2007) 72(4):430-41. doi:10.1038/sj.ki.5002334
12. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini Fill. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells (2011) 29:11-9. doi:10.1002/stem.559
13. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, et al. Mesenchymal stem cells derived from bone marrow favour tumor cell growth in vivo. Exp Mol Pathol (2006) 80(3):267-74. doi:10.1016/j.yexmp.2005.07.004
14. Yu IM, Jun ES, Bae YC, Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev (2008) 17:463-73. doi:10.1089/scd.2007.0181
15. Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D. Earlier onset of syngenic tumors in the presence of mesenchymal stem cells. Transplantation (2006) 82(8):1060-6. doi:10.1097/01.tp.0000236098.13804.0b
16. Ramasamy R, LamEW, Soeiro I,Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia (2007) 21:304-10. doi:10.1038/sj.leu.2404489
17. Wong RS. Mesenchymal stem cells: angels or demons? J Biomed Biotechnol (2011) 2011:459510. doi:10.1155/2011/459510
18. Khakoo AY, Pati S.Anderson SA, Reid W, Elshal MF, Rovirall, et al. Human mesenchymal stem cells exert potent anti-tumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 203(5):1235-47. doi:10.1084/jem.20051921
19. Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res (2008) 18(4):500-7. doi: 10.1038/cr.2008.40
20. Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, et al. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated Non-Hodgkin's lymphoma xenografts. PLoS One (2010) 6(6):el 1140. doi:10.1371/journal.pone.0011140
21. Li GC, Ye QH, Xue YH, Sun HI, Zhou HI, Ren N, et al. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci (2010) 101(12):2546-53. doi: 10.111 l/j.1349- 7006.2010.01738.x
22. Li L, Tian H, Chen Z, Yue W, Li S, Li W Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochim Biophys Sin (2011) 43:143-8. doi:10.1093/abbs/gmqll8
23. Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S, Bhattacharya I. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood (2009) 113:4197-205. doi:10.1182/blood-2008-09-176198
24. Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, et al. Stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One (2009) 4(7):e6278. doi:10.1371/joumal.pone. 0006278
25. Dong-Le Bourhis X,Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, et al. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int . J. Cancer (1997) 71(1):42-8. doi:10.1002/(SICI)1097-0215(19970328)71:l<42: :AID-UC9>3.0.CO;2-3
26. Lim YS, Lee JC, Lee YS, Lee BJ, Wang SG. Growth inhibitory effect of palatine tonsil-derived mesenchymal stem cells on head and neck squamous cell carcinoma cells. Clin Exp Otorhinolaryngol (2012) 5(2):86-93. doi:10.3342/ceo.2012. 5.2.86
27. Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behavior modulation by mesenchymal stromal cells. Mol Cancer (2010) 9:129. doi:10.1186/1476-4598-9-129
28. Tian LLH, Yue W, Zhu F, Li S, Li W Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol (2011) 226:1860-7. doi:10.1002/jcp.22511
29. Bruno S, Camussi G. Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol (2013) 28(12):2249-54. doi:10.1007/s00467-013- 2413-z
30. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics (2013) 13(10-11):1637-53. doi:10.1002/pmic.201200373
31. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/ microvesicles as a mechanism of cell-to-cell communication. Kidney Int (2010) 789:838-48. doi:10.1038/ki.2010.278
32. Kim HS, Choi DY, Yun SI, Choi SM, Kang JW, Jung JW, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res (2012) 11:839-49. doi:10.1021/pr200682z
33. Bruno S, Grange C, Deregibus MC,Calogero RA, SaviozziS,Collino F, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. JAm SocNephrol (2009) 20:1053-67. doi:10.1681/ASN.2008070798
34. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev (2013) 22:772-80. doi:10.1089/scd.2012.0266
35. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee II, Lotvall 10. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9(6):654-9. doi:10.1038/ncbl596
36. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One (2010) 5(7):el 1803. doi:10.1371/joumal.pone.0011803
37. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One (2009) 4:4722. doi:10.1371/journal.pone.0004722
38. Zhang Y, Liu D, Chen X, Li I, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 39(1):133-44. doi: 10.1016/j.molcel.2010.06.010
39. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem (2010) 285(23): 17442-52. doi:10.1074/jbc.M110.107821
40. Bruno S, Collino F, Deregibus MC, Grange C, Tetta C, Camussi G. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev (2013) 22(5):758-71. doi:10.1089/scd.2012.0304
41. WuS, JuGQ, DuT, ZhuYJ, LiuGH. Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro andin vivo. PLoS One (2013) 8(4):e61366. doi:10.1371/joumal. pone.0061366
42. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells (2012) 30(9):1985-98. doi:10.1002/stem.H61
43. Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett (2012) 586(7):1038-43. doi:10.1016/j.febslet.2012.02.050
44. Dong YW, Wang R, Cai QQ, Qi B, Wu W, Zhang YH, et al. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. JHepatol (2014) 60(4):792-801. doi:10.1016/j.jhep.2013.12.004
45. Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res (2010) 70:1906-15. doi:10.1158/0008-5472.CAN-09-3875
46. Karnuth B, Dedy N, Spieker T, Lawlor ER, Gattenlohner S, Ranft A, et al. Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. PLoS One (2014) 9(3):e93067. doi:10.1371/joumal.pone.0093067
47. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology (2009) 49(5):1571-82. doi:10.1002/hep.22806
48. Yin J, Tang HF, Xiang Q, Yu J, Yang XY, Hu N, et al. MiR-122 increases sensitivity of drug-resistant BEL-7402/5-FU cells to 5-fluorouracil via down-regulation of bcl-2 family proteins. Pharmazie (2011) 66:975-81.
49. Wang G, Dong X, Tian W, Lu Y, Hu J, Liu Y, etal. Evaluation of miR-122- regulated suicide gene therapy for hepatocellular carcinoma in an orthotopic mouse model. Chin J Cancer Res (2013) 25(6):646-55. doi:10.3978/j.issn.l000- 9604.2013.11.07
50. Duan Q, Wang X, Gong W, Ni L, Chen C, He X, et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One (2012) 7:e31518. doi:10.1371/joumal.pone.0031518
51. Lu S, Gao Y, Huang X, Wang X. Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization. Int J Biol Sci (2014) 10(4):415-25. doi:10.7150/ijbs.8002
52. Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, et al. Identification of miR-214 as a negative regulator of colorectal cancer liver metastasis via regulation of FGFR1 expression. Hepatology (2014) 60(2):598-609. doi:10.1002/hep.27118
53. Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One (2013) 12:e84256. doi:10.1371/ joumal.pone.0084256
54. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 27(1):e116. doi:10.1371/joumal.pone.0000116
55. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett (2012) 315(1):28-37. doi:10.1016/j.canlet.2011.10.002
56. Du T, Ju G, Wu S, Cheng Z, Cheng J, Zou X, et al. Microvesicles derived from human Wharton's jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor. PLoS One (2014) 9(5):e96836. doi:10.1371/joumal.pone.0096836
57. Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett (2013) 335(1):201-4. doi:10.1016/j.canlet.2013.02.019
58. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, et al. Exosomemediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells (2012) 30(7):1556-64. doi:10.1002/stem.H29
59. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol (2011) 29(4):341-5. doi:10.1038/nbt.l807
60. Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther (2011) 19(2):395-9. doi:10.1038/mt.2010.254
61. van den Boorn JG, Schlee M, Coch C, Hartmann G. SiRNA delivery with exosome nanoparticles. Nat Biotechnol (2011) 29(4):325-6. doi:10.1038/nbt.l830
62. El Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev (2013) 65(3):391-7. doi:10.1016/j.addr.2012.08.008
63. Xu C, Lin L, Cao G, Chen Q, Shou P, Huang Y, et al. Interferon-a-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene (2013). doi:10.1038/onc.2013.458
64. Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med (2011) 25(9):47. doi:10.1186/1479-5876-9-47